-
1
-
-
16444377083
-
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs
-
Zhou S, Chan SY, Goh BC, Chan E, Duan W, Huang M, et al. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet. 2005;44: 279-304.
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 279-304
-
-
Zhou, S.1
Chan, S.Y.2
Goh, B.C.3
Chan, E.4
Duan, W.5
Huang, M.6
-
2
-
-
33645809139
-
The human intestinal cytochrome P450 "pie"
-
Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. The human intestinal cytochrome P450 "pie". Drug Metab Dispos. 2006;34: 880-886.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 880-886
-
-
Paine, M.F.1
Hart, H.L.2
Ludington, S.S.3
Haining, R.L.4
Rettie, A.E.5
Zeldin, D.C.6
-
3
-
-
33748539303
-
Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice
-
Jin M, Shimada T, Yokogawa K, Nomura M, Ishizaki J, Piao Y, et al. Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice. Biochem Pharmacol. 2006;72: 1042-1050.
-
(2006)
Biochem Pharmacol
, vol.72
, pp. 1042-1050
-
-
Jin, M.1
Shimada, T.2
Yokogawa, K.3
Nomura, M.4
Ishizaki, J.5
Piao, Y.6
-
4
-
-
77649216536
-
Membrane transporters in drug development
-
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9: 215-236.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 215-236
-
-
Giacomini, K.M.1
Huang, S.M.2
Tweedie, D.J.3
Benet, L.Z.4
Brouwer, K.L.5
Chu, X.6
-
5
-
-
0031837161
-
Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted
-
Smit JW, Schinkel AH, Weert B, Meijer DK. Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted. Br J Pharmacol. 1998;124: 416-424.
-
(1998)
Br J Pharmacol
, vol.124
, pp. 416-424
-
-
Smit, J.W.1
Schinkel, A.H.2
Weert, B.3
Meijer, D.K.4
-
6
-
-
9444267085
-
Functional interaction of intestinal CYP3A4 and P-glycoprotein
-
Kivistö KT, Niemi M, Fromm MF. Functional interaction of intestinal CYP3A4 and P-glycoprotein. Fundam Clin Pharmacol. 2004;18: 621-626.
-
(2004)
Fundam Clin Pharmacol
, vol.18
, pp. 621-626
-
-
Kivistö, K.T.1
Niemi, M.2
Fromm, M.F.3
-
7
-
-
31144450001
-
Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone
-
Jin M, Shimada T, Yokogawa K, Nomura M, Kato Y, Tsuji A, et al. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone. Int J Pharm. 2006;309: 81-86.
-
(2006)
Int J Pharm
, vol.309
, pp. 81-86
-
-
Jin, M.1
Shimada, T.2
Yokogawa, K.3
Nomura, M.4
Kato, Y.5
Tsuji, A.6
-
8
-
-
71549157438
-
Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity
-
van Waterschoot RA, Lagas JS, Wagenaar E, van der Kruijssen CM, van Herwaarden AE, Song JY, et al. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. Cancer Res. 2009;69: 8996-9002.
-
(2009)
Cancer Res
, vol.69
, pp. 8996-9002
-
-
Van Waterschoot, R.A.1
Lagas, J.S.2
Wagenaar, E.3
Van Der Kruijssen, C.M.4
Van Herwaarden, A.E.5
Song, J.Y.6
-
9
-
-
1842536819
-
Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis
-
Masubuchi Y, Horie T. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug Metab Dispos. 2004;32: 437-441.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 437-441
-
-
Masubuchi, Y.1
Horie, T.2
-
10
-
-
58249125116
-
TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease
-
Chaluvadi MR, Nyagode BA, Kinloch RD, Morgan ET. TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease. Biochem Pharmacol. 2009;77: 464-471.
-
(2009)
Biochem Pharmacol
, vol.77
, pp. 464-471
-
-
Chaluvadi, M.R.1
Nyagode, B.A.2
Kinloch, R.D.3
Morgan, E.T.4
-
11
-
-
0024209382
-
Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis
-
Colli A, Buccino G, Cocciolo M, Parravicini R, Scaltrini G. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis. Clin Pharmacol Ther. 1988;44: 642-649.
-
(1988)
Clin Pharmacol Ther
, vol.44
, pp. 642-649
-
-
Colli, A.1
Buccino, G.2
Cocciolo, M.3
Parravicini, R.4
Scaltrini, G.5
-
12
-
-
0031750862
-
Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation
-
Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res. 1998;15: 706-711.
-
(1998)
Pharm Res
, vol.15
, pp. 706-711
-
-
Piquette-Miller, M.1
Pak, A.2
Kim, H.3
Anari, R.4
Shahzamani, A.5
-
13
-
-
33748170694
-
Liver disease selectively modulates cytochrome P450-mediated metabolism
-
Frye RF, Zgheib NK, Matzke GR, Chaves-Gnecco D, Rabinovitz M, Shaikh OS, et al. Liver disease selectively modulates cytochrome P450-mediated metabolism. Clin Pharmacol Ther. 2006;80: 235-245.
-
(2006)
Clin Pharmacol Ther
, vol.80
, pp. 235-245
-
-
Frye, R.F.1
Zgheib, N.K.2
Matzke, G.R.3
Chaves-Gnecco, D.4
Rabinovitz, M.5
Shaikh, O.S.6
-
14
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
-
(2002)
N Engl J Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
16
-
-
0028128047
-
Liver disease in ulcerative colitis: An epidemiological and follow up study in the county of Stockholm
-
Broomé U, Glaumann H, Hellers G, Nilsson B, Sörstad J, Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut. 1994;35: 84-89.
-
(1994)
Gut
, vol.35
, pp. 84-89
-
-
Broomé, U.1
Glaumann, H.2
Hellers, G.3
Nilsson, B.4
Sörstad, J.5
Hultcrantz, R.6
-
17
-
-
0033305621
-
Hepatobiliary manifestations of inflammatory bowel disease
-
Memon MI, Memon B, Memon MA. Hepatobiliary manifestations of inflammatory bowel disease. HPB Surg. 2000;11: 363-371.
-
(2000)
HPB Surg
, vol.11
, pp. 363-371
-
-
Memon, M.I.1
Memon, B.2
Memon, M.A.3
-
18
-
-
0027224059
-
Clinicopathologic study of dextran sulfate sodium experimental murine colitis
-
Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69: 238-249.
-
(1993)
Lab Invest
, vol.69
, pp. 238-249
-
-
Cooper, H.S.1
Murthy, S.N.2
Shah, R.S.3
Sedergran, D.J.4
-
19
-
-
33144485558
-
Role of interleukin 15 in colitis induced by dextran sulfate sodium in mice
-
Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulfate sodium in mice. Gut. 2006;55: 334-341.
-
(2006)
Gut
, vol.55
, pp. 334-341
-
-
Yoshihara, K.1
Yajima, T.2
Kubo, C.3
Yoshikai, Y.4
-
21
-
-
34547843601
-
Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats
-
Okayama M, Hayashi S, Aoi Y, Nishio H, Kato S, Takeuchi K. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats. Dig Dis Sci. 2007;52: 2095-2103.
-
(2007)
Dig Dis Sci
, vol.52
, pp. 2095-2103
-
-
Okayama, M.1
Hayashi, S.2
Aoi, Y.3
Nishio, H.4
Kato, S.5
Takeuchi, K.6
-
22
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25: 402-408.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
23
-
-
20344386201
-
Intestinal inflammation induces adaptation of P-glycoprotein expression and activity
-
Buyse M, Radeva G, Bado A, Farinotti R. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochem Pharmacol. 2005;69: 1745-1754.
-
(2005)
Biochem Pharmacol
, vol.69
, pp. 1745-1754
-
-
Buyse, M.1
Radeva, G.2
Bado, A.3
Farinotti, R.4
-
24
-
-
0027703377
-
Evaluation of EMIT Cyclosporine Assay for use with whole blood
-
Beresini MH, Davalian D, Alexander S, Toton-Quinn R, Barnett B, Cerelli MJ, et al. Evaluation of EMIT Cyclosporine Assay for use with whole blood. Clin Chem. 1993;39: 2235-2241.
-
(1993)
Clin Chem
, vol.39
, pp. 2235-2241
-
-
Beresini, M.H.1
Davalian, D.2
Alexander, S.3
Toton-Quinn, R.4
Barnett, B.5
Cerelli, M.J.6
-
25
-
-
0025181580
-
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
-
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98: 694-702.
-
(1990)
Gastroenterology
, vol.98
, pp. 694-702
-
-
Okayasu, I.1
Hatakeyama, S.2
Yamada, M.3
Ohkusa, T.4
Inagaki, Y.5
Nakaya, R.6
-
26
-
-
0032798911
-
Dextran sulfate sodium (DSS) colitis in rats: Clinical, structural, and ultrastructural aspects
-
Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, et al. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci. 1999;44: 1458-1475.
-
(1999)
Dig Dis Sci
, vol.44
, pp. 1458-1475
-
-
Gaudio, E.1
Taddei, G.2
Vetuschi, A.3
Sferra, R.4
Frieri, G.5
Ricciardi, G.6
-
27
-
-
30844462367
-
NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats
-
Reed KL, Fruin AB, Gower AC, Gonzales KD, Stucchi AF, Andry CD, et al. NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 2005;50: 2366-2378.
-
(2005)
Dig Dis Sci
, vol.50
, pp. 2366-2378
-
-
Reed, K.L.1
Fruin, A.B.2
Gower, A.C.3
Gonzales, K.D.4
Stucchi, A.F.5
Andry, C.D.6
-
28
-
-
66149137296
-
Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis
-
Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 2009;15: 341-352.
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 341-352
-
-
Alex, P.1
Zachos, N.C.2
Nguyen, T.3
Gonzales, L.4
Chen, T.E.5
Conklin, L.S.6
-
29
-
-
0033768784
-
Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency
-
Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Büchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 2000;62: 240-248.
-
(2000)
Digestion
, vol.62
, pp. 240-248
-
-
Egger, B.1
Bajaj-Elliott, M.2
Macdonald, T.T.3
Inglin, R.4
Eysselein, V.E.5
Büchler, M.W.6
-
30
-
-
0000245759
-
Portal bacteraemia in ulcerative colitis
-
Brooke BN, Slaney G. Portal bacteraemia in ulcerative colitis. Lancet. 1958;1: 1206-1207.
-
(1958)
Lancet
, vol.1
, pp. 1206-1207
-
-
Brooke, B.N.1
Slaney, G.2
-
31
-
-
0014682099
-
Portal bacteraemia in cases of ulcerative colitis submitted to colectomy
-
Eade MN, Brook BN. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet. 1969;1: 1008-1009.
-
(1969)
Lancet
, vol.1
, pp. 1008-1009
-
-
Eade, M.N.1
Brook, B.N.2
-
32
-
-
40849134144
-
Down-regulation of hepatic cytochrome P450 enzymes in rats with trinitrobenzene sulfonic acid-induced colitis
-
Masubuchi Y, Enoki K, Horie T. Down-regulation of hepatic cytochrome P450 enzymes in rats with trinitrobenzene sulfonic acid-induced colitis. Drug Metab Dispos. 2008;36: 597-603.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 597-603
-
-
Masubuchi, Y.1
Enoki, K.2
Horie, T.3
-
33
-
-
0024378410
-
Dextran sulfate is poorly absorbed after oral administration
-
Lorentsen KJ, Hendrix CW, Collins JM, Kornhauser DM, Petty BG, Klecker RW, et al. Dextran sulfate is poorly absorbed after oral administration. Ann Intern Med. 1989;111: 561-566.
-
(1989)
Ann Intern Med
, vol.111
, pp. 561-566
-
-
Lorentsen, K.J.1
Hendrix, C.W.2
Collins, J.M.3
Kornhauser, D.M.4
Petty, B.G.5
Klecker, R.W.6
-
34
-
-
0037379362
-
Bile salt transporters: Molecular characterization, function, and regulation
-
Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003;83: 633-671.
-
(2003)
Physiol Rev
, vol.83
, pp. 633-671
-
-
Trauner, M.1
Boyer, J.L.2
-
36
-
-
33645839049
-
Coordinated induction of bile acid detoxification and alternative elimination in mice: Role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids
-
Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol. 2006;290:G923-G932.
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.290
-
-
Zollner, G.1
Wagner, M.2
Moustafa, T.3
Fickert, P.4
Silbert, D.5
Gumhold, J.6
-
37
-
-
0035115303
-
Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice
-
Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol. 2001;1: 189-199.
-
(2001)
Int Immunopharmacol
, vol.1
, pp. 189-199
-
-
Hartmann, G.1
Kim, H.2
Piquette-Miller, M.3
-
38
-
-
0036786429
-
Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia
-
Hartmann G, Cheung AK, Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther. 2002;303: 273-281.
-
(2002)
J Pharmacol Exp Ther
, vol.303
, pp. 273-281
-
-
Hartmann, G.1
Cheung, A.K.2
Piquette-Miller, M.3
-
39
-
-
27444441206
-
Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver
-
Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol. 2005;289:G831-G841.
-
(2005)
Am J Physiol Gastrointest Liver Physiol
, vol.289
-
-
Geier, A.1
Dietrich, C.G.2
Voigt, S.3
Ananthanarayanan, M.4
Lammert, F.5
Schmitz, A.6
-
40
-
-
34250758597
-
Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways
-
Cerveny L, Svecova L, Anzenbacherova E, Vrzal R, Staud F, Dvorak Z, et al. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos. 2007;35: 1032-1041.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1032-1041
-
-
Cerveny, L.1
Svecova, L.2
Anzenbacherova, E.3
Vrzal, R.4
Staud, F.5
Dvorak, Z.6
-
41
-
-
77949911622
-
Activation of xenobiotic receptors: Driving into the nucleus
-
Li H, Wang H. Activation of xenobiotic receptors: driving into the nucleus. Expert Opin Drug Metab Toxicol. 2010;6: 409-426.
-
(2010)
Expert Opin Drug Metab Toxicol
, vol.6
, pp. 409-426
-
-
Li, H.1
Wang, H.2
-
42
-
-
1642579697
-
Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats
-
Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Dispos. 2004;32: 20-27.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 20-27
-
-
Kalitsky-Szirtes, J.1
Shayeganpour, A.2
Brocks, D.R.3
Piquette-Miller, M.4
-
43
-
-
33745805833
-
Role of NF-kappaB in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents
-
Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem. 2006;281: 17882-17889.
-
(2006)
J Biol Chem
, vol.281
, pp. 17882-17889
-
-
Gu, X.1
Ke, S.2
Liu, D.3
Sheng, T.4
Thomas, P.E.5
Rabson, A.B.6
-
44
-
-
38149062111
-
Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins
-
Lee CM, Kim BY, Li L, Morgan ET. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J Biol Chem. 2008;283: 889-898.
-
(2008)
J Biol Chem
, vol.283
, pp. 889-898
-
-
Lee, C.M.1
Kim, B.Y.2
Li, L.3
Morgan, E.T.4
-
45
-
-
84869122030
-
Involvement of ubiquitination in the decrease of intestinal P-glycoprotein in a streptozotocin-induced diabetic mouse model
-
Nawa A, Fujita-Hamabe W, Tokuyama S. Involvement of ubiquitination in the decrease of intestinal P-glycoprotein in a streptozotocin-induced diabetic mouse model. Drug Metab Pharmacokinet. 2012;27: 548-552.
-
(2012)
Drug Metab Pharmacokinet
, vol.27
, pp. 548-552
-
-
Nawa, A.1
Fujita-Hamabe, W.2
Tokuyama, S.3
-
46
-
-
12644272784
-
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
-
Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther. 1997;62: 248-260.
-
(1997)
Clin Pharmacol Ther
, vol.62
, pp. 248-260
-
-
Lown, K.S.1
Mayo, R.R.2
Leichtman, A.B.3
Hsiao, H.L.4
Turgeon, D.K.5
Schmiedlin-Ren, P.6
|